NYSE:TEVA
Teva Pharmaceutical Industries Limited Stock News
$16.81
+0.520 (+3.19%)
At Close: May 20, 2024
National Pension Service Buys General Electric Co, Analog Devices Inc, Occidental Petroleum ...
03:38pm, Thursday, 18'th Nov 2021 GuruFocus
Related Stocks: ADI , ON , DVN , OXY , PCG , WDC , GE , STLD , CZR , IPG , BBWI , SNA , CCK , JBHT , TEVA , FBHS , WRK , ALXN , MXIM , WORK , NLY , DTM , CBOE ,
STAT+: Pharmalittle: SEC probes Cassava over Alzheimers drug results; Teva takes pharma in a new direction with a bond sale
02:23pm, Thursday, 18'th Nov 2021 STAT News
The SEC is investigating claims Cassava Sciences manipulated research results of its experimental Alzheimers drug.
STAT+: By selling bonds tied to drug access and climate goals, Teva takes pharma in a new direction
01:52pm, Thursday, 18'th Nov 2021 STAT News
In a first-of-its-kind move by a drug maker, Teva Pharmaceuticals recently sold $5 billion in bonds tied directly to its progress on climate change and access to medicines goals.
New filing by TEVA PHARMACEUTICALS USA INC. POLITICAL ACTION COMMITTEE (TEVA PAC)
04:33pm, Wednesday, 17'th Nov 2021 The FEC
The TEVA PHARMACEUTICALS USA INC. POLITICAL ACTION COMMITTEE (TEVA PAC) successfully filed their F3XN NOVEMBER MONTHLY with the coverage period of 10/01/2021 to 10/31/2021 and a confirmation ID of FEC-1548599 *********CommitteeId: C00434811 | FilingId: 1548599 | FormType: F3XN | CoverageFrom: 10/01/2021 | CoverageThrough: 10/31/2021 | ReportType: NOVEMBER MONTHLY*********
Teva Pharmaceutical Industries Limited (NYSE: TEVA): Todays Most-Watched Stocks
01:00pm, Wednesday, 17'th Nov 2021 Marketing Sentinel
In the last trading session, 7.75 million Teva Pharmaceutical Industries Limited (NYSE:TEVA) shares changed hands as the companys beta touched 1.30. With the companys per share price at $9.30 changed hands at -$0.14 or -1.48% during last session, the market valuation stood at $10.36B. TEVAs last price was a discount, traded about -43.01% off its Teva Pharmaceutical Industries Limited (NYSE: TEVA): Todays Most-Watched Stocks Read More »
Antitumor Antibiotics Market Technology, Recent Trends, Future Growth & Forecast 2027 | Shyndec Pharmaceutical, Teva Pharmaceutical, KPC Pharmaceuticals
10:16am, Wednesday, 17'th Nov 2021 OpenPR
In the coming years, the global market for antitumor antibiotics is predicted to develop at a rapid rate. The rise in the prevalence of various types of cancer, as well as significant research and development activities in the field of
Overview of Global Bio Similar Market: The Global Bio Similar Market report is a skilful and deep analysis of the present situation and challenges. This report focuses on the key drivers, restraints, Market opportunities, threats and risks for Market major players.
Analysts Set Teva Pharmaceutical Industries Limited (NYSE:TEVA) PT at $10.67
01:30am, Wednesday, 17'th Nov 2021 Dakota Financial News
Teva Pharmaceutical Industries Limited (NYSE:TEVA) has earned a consensus recommendation of Hold from the six research firms that are presently covering the stock, Marketbeat reports. Five investment analysts have rated the stock with a hold recommendation. The average 12 month price target among brokers that have issued ratings on the stock in the last year []
Archon Partners LLC Buys Norwegian Cruise Line Holdings, Alight Inc, XPO Logistics Inc, Sells ...
10:38pm, Tuesday, 16'th Nov 2021 GuruFocus
Related Stocks: NCLH , XPO , ALIT , MCK , PCOR , TEVA , NEU , WPF.U , VMEO ,
Latanoprost Market May Set New Growth Story 2027|Pfizer, Mylan, Novartis, Apotex, Teva
01:46pm, Tuesday, 16'th Nov 2021 OpenPR
Global Latanoprost Market report is a specialized and in-depth research of the Latanoprost industry with a focus on the global market trend. The report aims to provide an overview of global Latanoprost market with detailed market segmentation by component, deployment
Multiple Sclerosis Market is the most relevant, unique, fair and creditable global market research report which is provided to the valuable customers and clients depending upon their specific business needs. The report endows with complete market analysis and forecasting, market
Global impetigo therapeutic market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and
Parkinsons Disease Drugs Market to reach USD 8,383.2 Million by 2026 | Market Projection By Technology, Major key players, Growth, Revenue, CAGR, Regional Analysis, Industry Forecast
09:08am, Monday, 15'th Nov 2021 Intrado Digital Media
Key Companies in Parkinsons Disease Drugs Market are Pfizer, Roche, Merck, Novartis, Orion Pharma, UCB, Teva Pharmaceutical, Vertical Pharmaceuticals, ACADIA Pharmaceuticals Inc., Impax Laboratories, Lundbeck and Others Key Players Key Companies in Parkinsons Disease Drugs Market are Pfizer, Roche, Merck, Novartis, Orion Pharma, UCB, Teva Pharmaceutical, Vertical Pharmaceuticals, ACADIA Pharmaceuticals Inc., Impax Laboratories, Lundbeck and Others Key Players
OTC Anti-Infective Drug Market Demands, Trend, Growth, Size and Top Companies Bayer, GSK, Teva, Johnson & Johnson, NOVARTIS
08:41am, Monday, 15'th Nov 2021 OpenPR
The OTC Anti-Infective Drug Market research report is one point solution for businesses to evolve, grow, and mature. It provides real-time data collection methods that can track niche products growth that aligns with your goals. The insights and statistical models
Endo: A Win In California But Equity Value Still A Question
06:44pm, Tuesday, 02'nd Nov 2021
Endo: A Win In California But Equity Value Still A Question